Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.

Lautner RQ, Villela DC, Fraga-Silva RA, Silva N, Verano-Braga T, Costa-Fraga F, Jankowski J, Jankowski V, Sousa F, Alzamora A, Soares E, Barbosa C, Kjeldsen F, Oliveira A, Braga J, Savergnini S, Maia G, Peluso AB, Passos-Silva D, Ferreira A, Alves F, Martins A, Raizada M, Paula R, Motta-Santos D, Klempin F, Pimenta A, Alenina N, Sinisterra R, Bader M, Campagnole-Santos MJ, Santos RA.

Circ Res. 2013 Apr 12;112(8):1104-11. doi: 10.1161/CIRCRESAHA.113.301077. Epub 2013 Feb 27. Erratum in: Circ Res. 2013 May 24;112(11):e156. Kemplin, Friederike [corrected to Klempin, Friederike].

PMID:
23446738
2.

New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D.

Etelvino GM, Peluso AA, Santos RA.

Curr Hypertens Rep. 2014 Jun;16(6):433. doi: 10.1007/s11906-014-0433-0. Review.

PMID:
24760442
3.

Alamandine: a new member of the angiotensin family.

Villela DC, Passos-Silva DG, Santos RA.

Curr Opin Nephrol Hypertens. 2014 Mar;23(2):130-4. doi: 10.1097/01.mnh.0000441052.44406.92. Review.

PMID:
24389733
4.

ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.

Mendoza-Torres E, OyarzĂșn A, Mondaca-Ruff D, Azocar A, Castro PF, Jalil JE, Chiong M, Lavandero S, Ocaranza MP.

Ther Adv Cardiovasc Dis. 2015 Aug;9(4):217-37. doi: 10.1177/1753944715597623. Epub 2015 Aug 13. Review.

PMID:
26275770
5.

[Effects of ACE2-Ang 1-7-Mas axis on blood vessel].

Liu CQ, Huang Y, Lu LM.

Sheng Li Ke Xue Jin Zhan. 2007 Jan;38(1):43-8. Review. Chinese.

PMID:
17438952
6.

Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.

Fraga-Silva RA, Ferreira AJ, Dos Santos RA.

Curr Hypertens Rep. 2013 Feb;15(1):31-8. doi: 10.1007/s11906-012-0324-1. Review.

PMID:
23212695
7.

Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.

Nunes-Silva A, Rocha GC, Magalhaes DM, Vaz LN, Salviano de Faria MH, Simoes E Silva AC.

Protein Pept Lett. 2017 Nov 17;24(9):809-816. doi: 10.2174/0929866524666170728151401. Review.

PMID:
28758593
8.

Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.

Varagic J, Ahmad S, VonCannon JL, Moniwa N, Brosnihan KB, Wysocki J, Batlle D, Ferrario CM.

Am J Hypertens. 2013 May;26(5):583-90. doi: 10.1093/ajh/hps090. Epub 2013 Mar 4.

9.

ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.

SimÔes E Silva AC, Teixeira MM.

Pharmacol Res. 2016 May;107:154-162. doi: 10.1016/j.phrs.2016.03.018. Epub 2016 Mar 17. Review.

PMID:
26995300
10.

Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.

Jesus ICG, Scalzo S, Alves F, Marques K, Rocha-Resende C, Bader M, Santos RAS, Guatimosim S.

Am J Physiol Cell Physiol. 2018 Jun 1;314(6):C702-C711. doi: 10.1152/ajpcell.00153.2017. Epub 2018 Feb 14.

PMID:
29443552
11.

ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Xu P, Sriramula S, Lazartigues E.

Am J Physiol Regul Integr Comp Physiol. 2011 Apr;300(4):R804-17. doi: 10.1152/ajpregu.00222.2010. Epub 2010 Dec 22. Review.

12.

Hypotensive effect induced by microinjection of Alamandine, a derivative of angiotensin-(1-7), into caudal ventrolateral medulla of 2K1C hypertensive rats.

Soares ER, Barbosa CM, Campagnole-Santos MJ, Santos RAS, Alzamora AC.

Peptides. 2017 Oct;96:67-75. doi: 10.1016/j.peptides.2017.09.005. Epub 2017 Sep 8.

PMID:
28889964
13.

Angiotensin-(1-7) and the renin-angiotensin system.

Santos RA, Ferreira AJ.

Curr Opin Nephrol Hypertens. 2007 Mar;16(2):122-8. Review.

PMID:
17293687
14.

Angiotensin-(1-7): beyond the cardio-renal actions.

Passos-Silva DG, Verano-Braga T, Santos RA.

Clin Sci (Lond). 2013 Apr;124(7):443-56. doi: 10.1042/CS20120461. Review.

PMID:
23249272
15.

Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

Santos RA, Ferreira AJ, Verano-Braga T, Bader M.

J Endocrinol. 2013 Jan 18;216(2):R1-R17. doi: 10.1530/JOE-12-0341. Print 2013 Feb. Review.

PMID:
23092879
16.

Pathophysiological role of the renin-angiotensin system on erectile dysfunction.

Fraga-Silva RA, Montecucco F, Mach F, Santos RA, Stergiopulos N.

Eur J Clin Invest. 2013 Sep;43(9):978-85. doi: 10.1111/eci.12117. Epub 2013 Jun 12. Review.

PMID:
23909886
17.

ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.

Rabelo LA, Alenina N, Bader M.

Hypertens Res. 2011 Feb;34(2):154-60. doi: 10.1038/hr.2010.235. Epub 2010 Dec 2. Review.

PMID:
21124322
18.

New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.

Zhuo JL, Li XC.

Peptides. 2011 Jul;32(7):1551-65. doi: 10.1016/j.peptides.2011.05.012. Epub 2011 Jun 14. Review.

19.

Renin-angiotensin system revisited.

Fyhrquist F, Saijonmaa O.

J Intern Med. 2008 Sep;264(3):224-36. doi: 10.1111/j.1365-2796.2008.01981.x. Review.

20.

ACE2: more of Ang-(1-7) or less Ang II?

Ferrario CM.

Curr Opin Nephrol Hypertens. 2011 Jan;20(1):1-6. doi: 10.1097/MNH.0b013e3283406f57. Review.

Supplemental Content

Support Center